Questions? Connect with a Hemophilia Territory Manager

    The zip code you entered is not valid.

    X

    Contact at or

    Ready to help you define YOUR IXPERIENCE

    Hemophilia Sales Director, National Sales

    Orson Lovelace

    Orson Lovelace

    “As someone who has faced medical challenges, I see life, success, and relationships a little differently. I know that a condition does not have to steal someone’s future.”

    Contact Orson: 336-848-8749 or orson.lovelace@medexus.com

    Senior Director, Marketing and Patient Experience

    Grant_headshot2020v2

    Grant Belsham

    “Every day I am inspired by people in the bleeding disorders community – their energy, positivity, and support for each other make me proud to be part of their lives.”

    Contact Grant: 215-370-9818 or grant.belsham@medexus.com

    Community Experience Manager

    Myles Ganley

    Myles Ganley

    “My own diagnosis keeps me very attached to this community as a family. I love seeing someone with a bleeding disorder accomplish something they thought they couldn’t, and I live for helping them to get there.”

    Contact Myles: 208-602-0780 or myles.ganley@medexus.com

    Hemophilia Territory Managers

    AaronGreene_Resized-200x200px

    Aaron Greene

    Central & Eastern PA/DE/MD/DC/VA/NJ

    “Working in the hemophilia community gives me true inspiration. Hearing the shared stories of strength and bravery provides an example on how to live my life to the fullest.”

    Contact Aaron: 410-262-7035 or aaron.greene@medexus.com

    Dave Todd

    Dave Todd

    ND/SD/MN/WI/IL/NE/IA/KS/MO

    “After more than 20 years working in the bleeding disorders community, I am still inspired and motivated by the friends and families I meet everyday.”

    Contact Dave: 636-542-2355 or dave.todd@medexus.com

    Hope Woodcock-Ross

    Hope Woodcock-Ross

    ME/NH/VT/MA/RI/CT/NY

    “The bleeding disorders community has been my passion for over 20 years. My hope for every person and family affected by a bleeding disorder is to be educated so they can advocate for their care. Every person deserves to live their best life.”

    Contact Hope: 607-222-8412 or hope.woodcockross@medexus.com

    Ken Macomber

    Ken Macomber

    WA/OR/ID/MT/WY/CO/AK/UT

    “As a father and husband of individuals with hemophilia, the bleeding disorders community is very close to my heart, and I’m both inspired and humbled to be a part of it. My goal is to be a trusted resource and provide the best IXperience to the community, making their tomorrow better!”

    Contact Ken: 702-285-2435 or ken.macomber@medexus.com

    MeredithPaige_Resized-200x200px

    Meredith Paige

    CA/NV/AZ/HI

    “One of my favorite childhood memories was being 'Santa's Helper' at a hemophilia chapter holiday party. I enjoyed attending chapter events as a child and now as an adult, I feel proud and happy to continue to carry on our family tradition of serving the bleeding disorders community.”

    Contact Meredith: 858-705-4279 or meredith.paige@medexus.com

    Michael McElhaney

    Michael McElhaney

    TN/NC/SC/GA/AL/MS

    “Having a family member with a life long blood disorder, I have observed first hand the impact on the patient and their loved ones. I am very excited to be on this journey with the bleeding disorders community.”

    Contact Michael: 678-524-4385 or michael.mcelhaney@medexus.com

    Steve Calderon

    Steve Calderon

    NM/TX/OK

    “As someone with a rare blood disorder, I am honored to connect with and motivate the future leaders of my community. It is my hope to show every member of this community that they are not alone.”

    Contact Steve: 214-886-4035 or steve.calderon@medexus.com

    INDICATIONS AND IMPORTANT SAFETY INFORMATION

    Expand

    What is IXINITY?

    IXINITY [coagulation factor IX (recombinant)] is a medicine used to replace clotting factor (factor IX) that is missing in adults and children at least 12 years of age with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease. Hemophilia B is an inherited bleeding disorder that prevents clotting. Your healthcare provider may give you IXINITY for routine prophylaxis, for on demand treatment to control bleeding episodes or when you have surgery.

    IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B.

    IMPORTANT SAFETY INFORMATION for IXINITY

    • You should not use IXINITY if you are allergic to hamsters or any ingredients in IXINITY.

    • You should tell your healthcare provider if you have or have had medical problems, take any medicines, including prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies, have any allergies, including allergies to hamsters, are nursing, are pregnant or planning to become pregnant, or have been told that you have inhibitors to factor IX.

    • You can experience an allergic reaction to IXINITY. Contact your healthcare provider or get emergency treatment right away if you develop a rash or hives, itching, tightness of the throat, chest pain, or tightness, difficulty breathing, lightheadedness, dizziness, nausea, or fainting.

    • Your body may form inhibitors to IXINITY. An inhibitor is part of the body's defense system. If you develop inhibitors, it may prevent IXINITY from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for development of inhibitors to IXINITY.

    • If you have risk factors for developing blood clots, the use of IXINITY may increase the risk of abnormal blood clots.

    • Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY.

    • The most common side effect that was reported with IXINITY during clinical trials was headache.

    • These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.


    For more information about IXINITY, please see full Prescribing Information, including Important Patient Information.

    You are encouraged to report adverse events related to Medexus Pharma products by calling 1-844-859-6675. If you prefer, you may contact the Food and Drug Administration directly. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.